UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$511M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$419M |
| 3 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$353M |
| 4 |
SPDR Gold Trust
GLD
|
+$285M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$258M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.21B |
| 2 |
iShares US Treasury Bond ETF
GOVT
|
+$1.14B |
| 3 |
Microsoft
MSFT
|
+$1.08B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$790M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$401M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.78% |
| 2 | Healthcare | 6.25% |
| 3 | Consumer Discretionary | 6.24% |
| 4 | Financials | 5.99% |
| 5 | Communication Services | 4.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4076
VanEck Brazil Small-Cap ETF
BRF
$20.5M
| $529K | ﹤0.01% |
31,655
-3,688
| -10% | -$54.9K |
|
4077
Cue Biopharma
CUE
$119M
| $529K | ﹤0.01% |
720
-312
| -30% | -$226K |
|
4078
National Healthcare
NHC
$3.39B
| $529K | ﹤0.01% |
8,327
+1,415
| +20% | +$94.9K |
|
4079
Nelnet
NNI
$4.48B
| $529K | ﹤0.01% |
11,074
-1,110
| -9% | -$51.9K |
|
4080
Afya
AFYA
$1.24B
| $528K | ﹤0.01% |
22,494
+20,981
| +1,387% | +$431K |
|
4081
CALL
Live Nation Entertainment
LYV
$42.7B
| $528K | ﹤0.01% |
11,900
-225,000
| -95% | -$9.86M |
|
4082
PRA Group
PRAA
$706M
| $528K | ﹤0.01% |
13,649
+13,279
| +3,589% | +$421K |
|
4083
Stratasys
SSYS
$782M
| $528K | ﹤0.01% |
33,299
-19,466
| -37% | -$329K |
|
4084
ORIX
IX
$43.1B
| $527K | ﹤0.01% |
42,785
-8,885
| -17% | -$109K |
|
|
ZYXI
4085
DELISTED
Zynex
ZYXI
| $527K | ﹤0.01% |
23,309
+11,247
| +93% | +$188K |
|
|
CFMS
4086
DELISTED
Conformis, Inc. Common Stock
CFMS
| $526K | ﹤0.01% |
25,658
-1,418
| -5% | -$29.6K |
|
4087
OraSure Technologies
OSUR
$268M
| $525K | ﹤0.01% |
45,034
-347,111
| -89% | -$4.51M |
|
4088
SFL Corp
SFL
$1.54B
| $525K | ﹤0.01% |
56,517
-22,931
| -29% | -$229K |
|
|
EMBJ
4089
Embraer S.A. ADS
EMBJ
$12.7B
| $524K | ﹤0.01% |
87,567
+58,945
| +206% | +$364K |
|
|
NVO
4090
CALL
Novo Nordisk
NVO
$207B
| $524K | ﹤0.01% |
16,000
| – | – |
|
4091
CALL
Alcon
ALC
$36.7B
| $522K | ﹤0.01% |
+9,100
| New | +$515K |
|
|
BNY
4092
CALL
Bank of New York Mellon
BNY
$109B
| $522K | ﹤0.01% |
13,500
| – | – |
|
|
BNY
4093
PUT
Bank of New York Mellon
BNY
$109B
| $522K | ﹤0.01% |
13,500
| – | – |
|
4094
Warrior Met Coal
HCC
$5.16B
| $522K | ﹤0.01% |
33,895
+23,271
| +219% | +$317K |
|
|
PDT
4095
John Hancock Premium Dividend Fund
PDT
$627M
| $522K | ﹤0.01% |
39,241
-7,654
| -16% | -$98.7K |
|
4096
Scorpio Tankers
STNG
$3.72B
| $522K | ﹤0.01% |
40,743
-25,449
| -38% | -$461K |
|
4097
JPMorgan BetaBuilders Canada ETF
BBCA
$11.3B
| $521K | ﹤0.01% |
11,524
+4,826
| +72% | +$206K |
|
4098
BlackRock MuniHoldings Fund
MHD
$605M
| $521K | ﹤0.01% |
34,913
-444
| -1% | -$6.47K |
|
4099
RELX
RELX
$61.7B
| $521K | ﹤0.01% |
22,105
+7,597
| +52% | +$174K |
|
|
BSMM
4100
DELISTED
Invesco BulletShares 2022 Municipal Bond ETF
BSMM
| $521K | ﹤0.01% |
20,674
+18,689
| +942% | +$469K |
|
Similar funds
UBS Group's Q2 2020 Portfolio in Review
As of Q2 2020, UBS Group held 8,813 positions worth $237B, up 12% from $212B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group withdrew a net $17.5B in Q2 2020, closing 776 positions and reducing 4,001 holdings. Its most notable exit was Allergan plc, an estimated $1.21B position sold in full.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, UBS Group opened a new position in Warner Music worth $87.9M.
- UBS Group's largest Q2 2020 buy was Warner Music: 2,981,053 shares worth $87.9M.
- UBS Group added most to Vanguard Morningstar Mid-Cap ETF in Q2 2020, an estimated $511M increase.
- UBS Group's biggest Q2 2020 reduction was iShares US Treasury Bond ETF, cutting an estimated $1.14B.
- UBS Group fully exited Allergan plc in Q2 2020, selling an estimated $1.21B.
- UBS Group's ten largest holdings make up 16% of its $237B portfolio in Q2 2020.
- UBS Group opened 706 new positions and closed 776 in Q2 2020.
- UBS Group's portfolio value rose 12% quarter-over-quarter to $237B.
Based on UBS Group's 13F filing for Q2 2020, filed 31 Jul 2020.